120 related articles for article (PubMed ID: 1965007)
1. Antifungal chemoprophylaxis in cancer children: a prospective randomized controlled study.
Caselli D; Aricò M; Michelone G; Cavanna C; Nespoli L; Burgio GR
Microbiologica; 1990 Oct; 13(4):347-51. PubMed ID: 1965007
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of itraconazole in prevention of fungal infections in neutropenic patients.
Thunnissen PL; Sizoo W; Hendriks WD
Neth J Med; 1991 Aug; 39(1-2):84-91. PubMed ID: 1660108
[TBL] [Abstract][Full Text] [Related]
3. [Prevention of fungal infections in children and adolescents with cancer].
Groll AH; Ritter J; Müller FM
Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW
Med Klin (Munich); 1991 Dec; 86 Suppl 1():11-3. PubMed ID: 1663200
[TBL] [Abstract][Full Text] [Related]
5. Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia: results of a prospective randomized phase III study. German AML Cooperative Group.
Kern W; Behre G; Rudolf T; Kerkhoff A; Grote-Metke A; Eimermacher H; Kubica U; Wörmann B; Büchner T; Hiddemann W
Cancer; 1998 Jul; 83(2):291-301. PubMed ID: 9669812
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients.
Nucci M; Biasoli I; Akiti T; Silveira F; Solza C; Barreiros G; Spector N; Derossi A; Pulcheri W
Clin Infect Dis; 2000 Feb; 30(2):300-5. PubMed ID: 10671332
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
[TBL] [Abstract][Full Text] [Related]
8. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
[TBL] [Abstract][Full Text] [Related]
9. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
Bow EJ; Laverdière M; Lussier N; Rotstein C; Cheang MS; Ioannou S
Cancer; 2002 Jun; 94(12):3230-46. PubMed ID: 12115356
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study.
Walsh TJ; Rubin M; Hathorn J; Gress J; Thaler M; Skelton J; McKnight J; Browne M; Marshall D; Cotton D
Arch Intern Med; 1991 Apr; 151(4):765-70. PubMed ID: 2012462
[TBL] [Abstract][Full Text] [Related]
11. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
Kibbler CC
Mycoses; 1999; 42 Suppl 2():121-4. PubMed ID: 10865918
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the treatment of systemic fungal infections.
Walsh TJ
Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615
[TBL] [Abstract][Full Text] [Related]
13. [Systemic mycotic infections].
Meunier F
Recenti Prog Med; 1990 Jan; 81(1):18-22. PubMed ID: 2173078
[TBL] [Abstract][Full Text] [Related]
14. Itraconazole in neutropenic patients.
van't Wout JW
Chemotherapy; 1992; 38 Suppl 1():23-6. PubMed ID: 1319311
[TBL] [Abstract][Full Text] [Related]
15. [Prophylaxis against mycoses in neutropenic patients].
Arning M; Aul C
Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
[TBL] [Abstract][Full Text] [Related]
16. Itraconazole versus ketoconazole for the prophylaxis of fungal infection in neutropenic children: results of two consecutive nonrandomized studies.
Ninane J; Sluysmans T; Vermylen C; De Beule K; Woestenborghs R; Cauwenbergh G; Cornu G
Pediatr Hematol Oncol; 1989; 6(4):349-53. PubMed ID: 2561916
[TBL] [Abstract][Full Text] [Related]
17. Scedosporium infection in immunocompromised patients: successful use of liposomal amphotericin B and itraconazole.
Barbaric D; Shaw PJ
Med Pediatr Oncol; 2001 Aug; 37(2):122-5. PubMed ID: 11496350
[TBL] [Abstract][Full Text] [Related]
18. Itraconazole in cryptococcal meningitis in pregnancy: a case report.
Chotmongkol V; Sookprasert A
J Med Assoc Thai; 1992 Oct; 75(10):606-8. PubMed ID: 1339091
[TBL] [Abstract][Full Text] [Related]
19. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.
Kelsey SM; Goldman JM; McCann S; Newland AC; Scarffe JH; Oppenheim BA; Mufti GJ
Bone Marrow Transplant; 1999 Jan; 23(2):163-8. PubMed ID: 10197802
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
Glasmacher A; Prentice AG
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]